Remdesivir FDA Approved (2020) for Hospitalized COVID-19 Patients – NIH Guidelines
In May 2020, the FDA issued an Emergency Use Authorization (EUA) for Remdesivir—the first antiviral drug approved to treat hospitalized COVID-19 patients. By October 2020, full approval followed, marking a ... Read More